Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early-stage breast cancer-The COOL study

被引:3
|
作者
Renehan, Steffi [1 ,2 ]
Tencic, Monika [2 ]
Jackson, Kylie [3 ]
Krishnasamy, Meinir [1 ,4 ,5 ]
机构
[1] Peter MacCallum Canc Ctr, Acad Nursing Unit, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Dept Nursing, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Dept Nursing, Melbourne, Vic, Australia
[5] Victorian Comprehens Canc Ctr, Melbourne, Vic, Australia
关键词
breast cancer; chemotherapy; co-production; nurse training; patient experience; scalp cooling; INDUCED ALOPECIA; MIXED-METHODS; BODY-IMAGE; HAIR LOSS; PREVENTION; INFORMATION; HYPOTHERMIA; IMPACT; QUESTIONNAIRE; EXPERIENCE;
D O I
10.1111/jocn.16160
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Aims and objectives: This study set out to understand the experiences and expectations of scalp cooling among women with early-stage breast cancer. The objective was to develop patient co-produced information resources to better inform and prepare women considering scalp cooling during chemotherapy. Background: Treatment-induced alopecia is a common concern among women preparing for chemotherapy. Evidence indicates that many women feel inadequately prepared for scalp cooling, resulting in potentially mitigable distress and disappointment. Design: A single-site, sequential, explanatory mixed-methods design was used. Participants included women with early-stage breast cancer who had previously or were currently using, scalp cooling. Women completed an online survey exploring scalp cooling experiences and expectations and self-selecting participants took part in one semi-structured, audio-recorded interview. Guidelines for Good Reporting of a Mixed Methods Study were followed. Results: Forty-nine women (69%) consented to take part in the survey and 23 took part in an interview. Most women described losing more hair than they expected. Many described feeling inadequately prepared for the discomfort of scalp cooling; the additional time needed to accommodate scalp cooling during treatment and, that they lacked information about self-care to help minimise hair loss. Importantly, several participants described variability in nurses' knowledge and practical skills regarding scalp cooling. Conclusions: To optimise experience of scalp cooling, women need comprehensive preparatory information about variability in efficacy of scalp cooling; time needed to accommodate scalp cooling; hair care during treatment, and the potential discomfort associated with it. They also need nurses to be confident and well informed about scalp cooling processes. Relevance to clinical practice: Our study led to the development of online, patient co-produced resources to help prepare and inform women considering using scalp cooling; and an online scalp cooling training module and checklist for nurses. Links to the resources are included in the manuscript.
引用
收藏
页码:3222 / 3234
页数:13
相关论文
共 50 条
  • [41] Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure
    Breedlove, Hollie A.
    Smith, Anne M.
    Burk, Raymond F.
    Hill, Kristina E.
    Shapiro, Charles L.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 97 (03) : 225 - 230
  • [42] Quantifying Chemotherapy Delivery in Older and Younger Women With Early-Stage Breast Cancer Using Longitudinal Cumulative Dose
    Pak, Joyce
    Nyrop, Kirsten A.
    Muss, Hyman B.
    Forster, Moriah K.
    Lund, Jennifer L.
    ONCOLOGIST, 2024, 29 (04) : 311 - 315
  • [43] Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study
    Veiga-Seijo, Raquel
    Pertega-Diaz, Sonia
    Perez-Lopez, Maria Eva
    Martinez, Lourdes Calvo
    Novoa, Silvia Antolin
    Gonzalez-Martin, Cristina
    JOURNAL OF FOOT AND ANKLE RESEARCH, 2023, 16 (01)
  • [44] A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer
    Arcangeli, G
    Pinnarò, P
    Rambone, R
    Giannarelli, D
    Benassi, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (01): : 161 - 167
  • [45] Health-related quality of life before and during chemotherapy in patients with early-stage breast cancer
    Binotto, Monique
    Reinert, Tomas
    Werutsky, Gustavo
    Zaffaroni, Facundo
    Schwartsmann, Gilberto
    ECANCERMEDICALSCIENCE, 2020, 14
  • [46] Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer
    Turnbull, Arran K.
    Patel, Samir
    Martinez-Perez, Carlos
    Rigg, Anne
    Oikonomidou, Olga
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 237 - 245
  • [47] Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer
    Arran K. Turnbull
    Samir Patel
    Carlos Martinez-Perez
    Anne Rigg
    Olga Oikonomidou
    Breast Cancer Research and Treatment, 2021, 186 : 237 - 245
  • [48] Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients
    Shozo Ohsumi
    Sachiko Kiyoto
    Mina Takahashi
    Seiki Takashima
    Kenjiro Aogi
    Sachie Shimizu
    Miyuki Doi
    Supportive Care in Cancer, 2021, 29 : 6119 - 6125
  • [49] Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer
    Mahin, Dana
    Lavasani, Sayeh Moazami
    Cristobal, Leon
    Patel, Niki Tank
    Sedrak, Mina
    Stewart, Daphne
    Waisman, James
    Yuan, Yuan
    Yu, Wai
    Samoa, Raynald
    Ruel, Nora
    Yost, Susan E. E.
    Lee, Hayley
    Kil, Sung Hee
    Mortimer, Joanne E. E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [50] Associations of social vulnerability index with patient-reported outcomes in women treated with chemotherapy for early-stage breast cancer
    Almond, Natalie
    Deal, Allison M.
    Page, Annie
    Nyrop, Kirsten A.
    Muss, Hyman B.
    ONCOLOGIST, 2024,